This has led to the hope that similar products may be developed for hMPV, and Moderna has recently started trials into a mRNA ...

Not many people had heard of human metapneumovirus, or HPMV, until a surge of recent cases in China made headlines.

The attention being paid to a Chinese outbreak of a virus often confused with flu is a sign that respiratory infection ...

Moderna advances combo vaccine for flu and COVID-19 with trials starting in March Pharmaceutical companies gear up to tackle ...

The Centers for Disease Control and Prevention is currently monitoring reports of a spike in human metapneumovirus (HMPV) in ...

Five years on from the first news of COVID, recent reports of an obscure respiratory virus in China may understandably raise ...

As China experiences a rise in respiratory infections this winter, one little-known virus has gotten a lot of attention – and ...

Cases of the respiratory virus known as HMPV - which has symptoms similar to those of the common cold, flu, and Covid-19 - have been surging in China, prompting fears that another global pandemic is ...

Moderna, Inc. (NASDAQ:MRNA – Get Free Report) fell 8.9% on Wednesday after UBS Group lowered their price target on the stock from $108.00 to $96.00. UBS Group currently has a buy rating on the stock.

GAMMA Investing LLC boosted its holdings in shares of Moderna, Inc. (NASDAQ:MRNA – Free Report) by 31.9% in the 4th quarter, ...

This has led to the hope that similar products may be developed for hMPV, and Moderna has recently started trials into a mRNA hMPV vaccine. There are no treatments that have been clearly ...